379 related articles for article (PubMed ID: 27852308)
1. Systems analysis identifies miR-29b regulation of invasiveness in melanoma.
Andrews MC; Cursons J; Hurley DG; Anaka M; Cebon JS; Behren A; Crampin EJ
Mol Cancer; 2016 Nov; 15(1):72. PubMed ID: 27852308
[TBL] [Abstract][Full Text] [Related]
2. Transcriptome stability profiling using 5'-bromouridine IP chase (BRIC-seq) identifies novel and functional microRNA targets in human melanoma cells.
Joshi P; Seki T; Kitamura S; Bergano A; Lee B; Perera RJ
RNA Biol; 2019 Oct; 16(10):1355-1363. PubMed ID: 31179855
[TBL] [Abstract][Full Text] [Related]
3. A combined approach identifies three mRNAs that are down-regulated by microRNA-29b and promote invasion ability in the breast cancer cell line MCF-7.
Wang C; Gao C; Zhuang JL; Ding C; Wang Y
J Cancer Res Clin Oncol; 2012 Dec; 138(12):2127-36. PubMed ID: 22864815
[TBL] [Abstract][Full Text] [Related]
4. The regulation of miRNA-211 expression and its role in melanoma cell invasiveness.
Mazar J; DeYoung K; Khaitan D; Meister E; Almodovar A; Goydos J; Ray A; Perera RJ
PLoS One; 2010 Nov; 5(11):e13779. PubMed ID: 21072171
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide analysis of MicroRNA-messenger RNA interactome in ex-vivo gill filaments, Anguilla japonica.
Ng HM; Ho JCH; Nong W; Hui JHL; Lai KP; Wong CKC
BMC Genomics; 2020 Mar; 21(1):208. PubMed ID: 32131732
[TBL] [Abstract][Full Text] [Related]
6. Identification of invasion-metastasis-associated microRNAs in hepatocellular carcinoma based on bioinformatic analysis and experimental validation.
Lou W; Chen J; Ding B; Chen D; Zheng H; Jiang D; Xu L; Bao C; Cao G; Fan W
J Transl Med; 2018 Sep; 16(1):266. PubMed ID: 30268144
[TBL] [Abstract][Full Text] [Related]
7. MiR-377 targets E2F3 and alters the NF-kB signaling pathway through MAP3K7 in malignant melanoma.
Zehavi L; Schayek H; Jacob-Hirsch J; Sidi Y; Leibowitz-Amit R; Avni D
Mol Cancer; 2015 Mar; 14():68. PubMed ID: 25889255
[TBL] [Abstract][Full Text] [Related]
8. Regulatory network of circRNA-miRNA-mRNA contributes to the histological classification and disease progression in gastric cancer.
Cheng J; Zhuo H; Xu M; Wang L; Xu H; Peng J; Hou J; Lin L; Cai J
J Transl Med; 2018 Aug; 16(1):216. PubMed ID: 30068360
[TBL] [Abstract][Full Text] [Related]
9. Identifying microRNA/mRNA dysregulations in ovarian cancer.
Miles GD; Seiler M; Rodriguez L; Rajagopal G; Bhanot G
BMC Res Notes; 2012 Mar; 5():164. PubMed ID: 22452920
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-195 acts as an anti-proliferative miRNA in human melanoma cells by targeting Prohibitin 1.
Cirilo PDR; de Sousa Andrade LN; Corrêa BRS; Qiao M; Furuya TK; Chammas R; Penalva LOF
BMC Cancer; 2017 Nov; 17(1):750. PubMed ID: 29126391
[TBL] [Abstract][Full Text] [Related]
11. Regulation of Melanoma Progression through the TCF4/miR-125b/NEDD9 Cascade.
Rambow F; Bechadergue A; Luciani F; Gros G; Domingues M; Bonaventure J; Meurice G; Marine JC; Larue L
J Invest Dermatol; 2016 Jun; 136(6):1229-1237. PubMed ID: 26968260
[TBL] [Abstract][Full Text] [Related]
12. NEAT1/miR-200b-3p/SMAD2 axis promotes progression of melanoma.
Zhou WJ; Wang HY; Zhang J; Dai HY; Yao ZX; Zheng Z; Meng-Yan S; Wu K
Aging (Albany NY); 2020 Nov; 12(22):22759-22775. PubMed ID: 33202380
[TBL] [Abstract][Full Text] [Related]
13. ADAM12-L is a direct target of the miR-29 and miR-200 families in breast cancer.
Duhachek-Muggy S; Zolkiewska A
BMC Cancer; 2015 Mar; 15():93. PubMed ID: 25886595
[TBL] [Abstract][Full Text] [Related]
14. Microrna profiling analysis of differences between the melanoma of young adults and older adults.
Jukic DM; Rao UN; Kelly L; Skaf JS; Drogowski LM; Kirkwood JM; Panelli MC
J Transl Med; 2010 Mar; 8():27. PubMed ID: 20302635
[TBL] [Abstract][Full Text] [Related]
15. IL-10Rα expression is post-transcriptionally regulated by miR-15a, miR-185, and miR-211 in melanoma.
Venza I; Visalli M; Beninati C; Benfatto S; Teti D; Venza M
BMC Med Genomics; 2015 Dec; 8():81. PubMed ID: 26631117
[TBL] [Abstract][Full Text] [Related]
16. MiR-21 enhances melanoma invasiveness via inhibition of tissue inhibitor of metalloproteinases 3 expression: in vivo effects of MiR-21 inhibitor.
Martin del Campo SE; Latchana N; Levine KM; Grignol VP; Fairchild ET; Jaime-Ramirez AC; Dao TV; Karpa VI; Carson M; Ganju A; Chan AN; Carson WE
PLoS One; 2015; 10(1):e0115919. PubMed ID: 25587717
[TBL] [Abstract][Full Text] [Related]
17. miR-150 Suppresses Tumor Growth in Melanoma Through Downregulation of MYB.
Sun X; Zhang C; Cao Y; Liu E
Oncol Res; 2019 Feb; 27(3):317-323. PubMed ID: 29690954
[TBL] [Abstract][Full Text] [Related]
18. Loss of post-transcriptional regulation of DNMT3b by microRNAs: a possible molecular mechanism for the hypermethylation defect observed in a subset of breast cancer cell lines.
Sandhu R; Rivenbark AG; Coleman WB
Int J Oncol; 2012 Aug; 41(2):721-32. PubMed ID: 22664488
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-31 controls G protein alpha-13 (GNA13) expression and cell invasion in breast cancer cells.
Rasheed SA; Teo CR; Beillard EJ; Voorhoeve PM; Zhou W; Ghosh S; Casey PJ
Mol Cancer; 2015 Mar; 14():67. PubMed ID: 25889182
[TBL] [Abstract][Full Text] [Related]
20. Network modeling identifies molecular functions targeted by miR-204 to suppress head and neck tumor metastasis.
Lee Y; Yang X; Huang Y; Fan H; Zhang Q; Wu Y; Li J; Hasina R; Cheng C; Lingen MW; Gerstein MB; Weichselbaum RR; Xing HR; Lussier YA
PLoS Comput Biol; 2010 Apr; 6(4):e1000730. PubMed ID: 20369013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]